FDA Details Thinking for Streamlining Development of Cell, Gene, Regenerative Therapies
Three draft recommendation documents published on Wednesday are intended to guide drug sponsors and accelerate the development of cell and gene therapies.
FDA Details Thinking for Streamlining Development of Cell, Gene, Regenerative Therapies Read More »
